Skip to main content
. 2018 Apr 17;7(5):663–672. doi: 10.1530/EC-18-0089

Table 3.

Anthropometric, metabolic, and psychiatric parameters of patients with Prader–Willi syndrome according to GH treatment in childhood and transition status.

Group not treated by GH (n = 61) Group treated by GH (n = 34)
Transition (n = 12) No transition (n = 49) P Transition (n = 19) No transition (n = 15) P
Age (year) 25.7 ± 5.8 32.8 ± 9.8 0.02 23.2 ± 3.8 28.7 ± 6.3 <0.01
Female gender 7 (58.3) 30 (61.2) 1 10 (52.6) 4 (26.7) 0.24
Weight (kg) 83.3 ± 18.6 104.8 ± 32.9 0.03 78.0 ± 19.4 102.0 ± 27.8 <0.01
Height (cm) 152 ± 8 152 ± 12 0.96 160 ± 11 160 ± 9 0.88
BMI (kg/m2) 35.9 ± 7.9 44.7 ± 12.7 0.03 30.4 ± 7.1 39.2 ± 10.2 <0.01
Obesity 9 (75.0) 39 (79.6) 0.82 9 (47.4) 11 (73.3) 0.14
Grade III obesity (%) 5 (41.7) 31 (63.3) 0.22 2 (10.5) 8 (53.3) <0.01
Body composition
 Fat mass (%) 51.0 ± 4.0 51.5 ± 5.6 0.80 44.9 ± 7.2 49.2 ± 6.9 0.11
 Fat mass (kg) 39.5 ± 9.4 53.8 ± 19.0 0.01 34.5 ± 10.9 47.6 ± 14.7 <0.01
 Lean body mass (kg) 37.9 ± 7.7 47.2 ± 13.0 0.02 39.2 ± 9.3 47.7 ± 11.9 0.03
 Fat mass index (kg/m2) 17.0 ± 3.6 23.1 ± 7.5 <0.01 13.7 ± 4.8 18.7 ± 6.4 0.02
 Trunk fat mass/appendicular fat mass 0.9 ± 0.2 1.0 ± 0.2 0.30 0.8 ± 0.3 1.0 ± 0.3 0.02
Metabolic parameters
 Type 2 diabetes 4 (33.3) 18 (36.7) 1 2 (10.5) 3 (15.8) 0.70
 High blood pressure* 1 (8.3) 13 (26.5) 0.30 0 2 (13.3) 0.32
Behavior
 Neuroleptic treatment 7 (58.3) 27 (55.1) 1 3 (15.8) 8 (53.3) 0.03
 Antidepressant treatment 3 (25.0) 16 (32.7) 0.80 1 (5.3) 9 (60.0) <0.001
 Hospitalization in psychiatry 2 (16.7) 16 (32.7) 0.41 4 (21.1) 6 (31.6) 0.26

*Systolic blood pressure >140 mmHg or diastolic blood pressure >90 mmHg. The fat mass index was calculated as fat mass in kg divided by height squared (kg/m2).